• Corpus ID: 53545215

Recent Drug Delivery Systems for Treatment of Glaucoma

@inproceedings{ElSalamounia2016RecentDD,
  title={Recent Drug Delivery Systems for Treatment of Glaucoma},
  author={Noha S El-Salamounia and R Dewi Mutia Farida},
  year={2016}
}
Elevated Intraocular Pressure (IOP) is the most important risk factor for the development of glaucoma, its reduction is achieved mostly by topical administration of anti-glaucoma drugs as eye drops. A major problem that reduces the clinical efficacy of these drugs is the attainment of an optimal drug concentration at the site of action. To achieve effective ocular hypotensive effect, an adequate amount of the drug should be delivered to the eye and maintained in the ocular tissues for a… 

Tables from this paper

Therapeutic Nanoparticles and Their Targeted Delivery Applications

Understanding of the characteristics of nanoparticles and their interactions with the biological environment will enable us to establish novel strategies for the treatment, prevention, and diagnosis in many diseases, particularly untreatable ones.

Suvremeni farmaceutski oblici za topikalno liječenje glaukoma

Cilj istraživanja Cilj ovog rada je opisati svojstva i razvoj novih farmaceutskih oblika za topikalno lijecenje glaukoma. Shodno tome, opisat ce

Sustained drug delivery in glaucoma

Novel delivery systems for providing sustained drug delivery in glaucoma will allow for more targeted medical therapy and for the opportunity to further explore neuroprotective and gene-based therapies.

Recent advances in ocular drug delivery

Sustained drug release and increase in drug bioavailability have been obtained, offering the promise of innovation in drug delivery systems for ocular administration and Combining different properties of pharmaceutical formulations appears to offer a genuine synergy in bioavailability and sustained release.

Ocular Drug Delivery Systems for Treatment of Glaucoma

Various approaches like niosomes, liposomes, hydrogels, nanoparticles, nanosuspensions, microparticles, microemulsions, prodrugs and ocular inserts are explored to improve the ocular bioavailability of drug and provide continuous and controlled release of the drug to the anterior and posterior chamber of the eye.

Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.

  • Kuan-Hui HsuB. CarbiaC. PlummerA. Chauhan
  • Biology, Medicine
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
  • 2015

Contact lenses as a platform for ocular drug delivery

The in vivo animal and clinical studies have proven the safety and efficacy of drug-eluting contact lenses, while showing considerable improvements compared to eye drops, and several challenges remain such as processing and storage issues, regulatory hurdles, high costs of clinical studies, potential lack of acceptance by the elderly, etc.

Novel Approaches in Formulation and Drug Delivery using Contact Lenses

Progress has been made to develop drug-eluting contact lens using different techniques, which have the potential to control and sustain the delivery of drug.

Drug Delivery by Contact Lens in Spontaneously Glaucomatous Dogs

Ophthalmic drug delivery through contact lenses increases bioavailability and reduces systemic drug uptake, suggesting higher bioavailability for contact lenses compared to eye drops.

Extended drug delivery by contact lenses for glaucoma therapy.

...